Stocks and Investing
Stocks and Investing
Wed, March 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Charlie Chan Upgraded (ACMR) to Buy on, Mar 7th, 2023
Charlie Chan of Morgan Stanley, Upgraded "ACM Research, Inc." (ACMR) to Buy on, Mar 7th, 2023.
Charlie has made no other calls on ACMR in the last 4 months.
There are 3 other peers that have a rating on ACMR. Out of the 3 peers that are also analyzing ACMR, 0 agree with Charlie's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Charlie
- Mark Miller of "Benchmark" Reiterated at Strong Buy and Held Target at $32 on, Monday, February 27th, 2023
- Nick Cheng of "Jefferies" Downgraded from Hold to Sell and Increased Target to $8 on, Monday, February 27th, 2023
- Quinn Bolton of "Needham" Reiterated at Strong Buy and Held Target at $15 on, Monday, February 27th, 2023
Contributing Sources